Manu Jain, M.D.
As a trained pathologist, I had a unique opportunity to work in three continents (Asia, Europe and America) and gained over 12 years of extensive knowledge not only in conventional pathology but also in ground-breaking translational research. My main focus since joining Cornell has been in vivo microscopy. In vivo microscopy techniques, such as multiphoton microscopy (MPM) and full field optical coherence tomography (FFOCT) can generate high resolution histology quality images in real-time without the need for tissue processing, a quintessential step in conventional histopathology. Thus these techniques can be used for real-time, intra-operative diagnosis that will reduce the rate of benign biopsies and its associated complications. In addition, these techniques can also aid pathogists in quick evaluation of ex vivo tissues.Thus can be used as an adjunct or eventually an alternative tool to frozen section analysis. In addition, it can aslo be used for tissue selection in bio banking and organ transplant.
Dr. Jain obtained her MD in Pathology, from Jawaharlal Nehru Medical College, Aligarh, India. She then worked as a senior resident in the department of anatomic-pathology, University College of Medical Sciences, New Delhi, India. Later, she moved to France, where she did rotating fellowship, in the departments of dermato-pathology, GI-pathology and endocrine-pathology, in René Descartes University, Paris.
Since joining Weill Cornell Medical College in early 2010, her main focus has been translational research, especially in vivo microscopy. She was employed by Department of Urology at Cornell as a Research Associate to validate and establish the utility of in vivo microscopy tools in gentio-urinary tumors. Since then she has extensively worked with cutting edge “optical imaging” technologies such as multiphoton microscopy (MPM) and full field optical coherence tomography (FFOCT) in detecting tumors (bladder, kidney, prostate, lung and gastrointestinal diseases) in humans. Recently she also worked in prostate cancer tumor bank as a pathologist.
United States and Canadian Academy of Pathology (USCAP)
International Academy of Pathology (IAP)
European Association of Urology (EAU)